Philips pens 2 long-term equipment and consulting deals with German hospitals for over €140M

Austrian hotel group Vienna House has launched its newest brand, Vienna House R.evo.
Philips also signed an eight-year consultancy and equipment agreement with Munich Municipal Hospital worth $58.6 million. (Alejandro/CC BY 2.0)

Royal Philips signed long-term partnerships with two hospital groups in Germany, agreeing to help reform their radiology workflows and supply medical imaging equipment, including its IQon Spectral CT hardware.

The Kliniken der Stadt Köln, or Clinics of Cologne, and Philips signed a 15-year contract worth about €90 million ($105.4 million), with Philips being responsible for the delivery, upgrade, replacement and maintenance of its precision diagnosis and therapy systems.

Philips also signed an eight-year consultancy and equipment agreement with Munich Municipal Hospital worth €50 million ($58.6 million), the Amsterdam-based company said. Philips plans to help the hospital system phase in and renew over 200 imaging systems, as well as provide clinical informatics support.

FREE DAILY NEWSLETTER

Like this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go.

“These partnerships underline Philips’ transition to becoming an integrated solutions provider that takes a holistic approach to meeting its customers’ needs,” Peter Vullinghs, CEO of Philips in Germany, Austria and Switzerland, said in a statement.

RELATED: Royal Philips acquires the U.K.’s Remote Diagnostic Technologies for undisclosed price

Under the Cologne agreement, Philips will help plan a new radiology unit, including the construction of a new building in Merheim, and help optimize operating procedures in radiology for children and adults. The deal covers all three of the clinic’s locations, in Holweide, Merheim and the Children’s Hospital Amsterdamer Strasse.

RELATED: Philips gets FDA nod for 2-in-1 imaging device

Meanwhile in Munich, Philips described the partnership as the largest medical technology project for a single clinic in Europe, with the goal of developing strategies for the municipal group to digitize its operations and connect care across its sites and medical disciplines.

“By combining innovative technology concepts that address the evolving needs of our patient population with continuous improvement of our processes, we aim to ensure cost-effective care for patients in the Munich region over the long-term,” said Axel Fischer, chairman of the board of management at the Munich system.

In addition, Philips will tackle departments’ designs and clinical processes to optimize planning and technology use, as well as aim to improve treatment outcomes and patient and staff experiences.

Suggested Articles

Novocure’s tumor-treating electric field system scored an FDA nod in mesothelioma, making it the first new treatment in more than 15 years.

To bring its nerve-stimulating wearable to market, Cala Health collected $50 million that it also plans to use to expand its therapeutic pipeline.

The FDA cleared a handful of diagnostics aimed at STIs, including the first to detect chlamydia and gonorrhea outside the genitals.